TR
T. Rowe Price Investment Management, Inc. disclosed a 8% stake in CABA
T. Rowe Price Investment Management, Inc. reported owning 8% of Cabaletta Bio, Inc. (CABA) (17,250,098 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.